- Home
- HRTX vs JGH Comparison
HRTX vs JGH Comparison
Compare HRTX & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- JGH
- Stock Information
- Founded
- HRTX 1983
- JGH 2014
- Country
- HRTX United States
- JGH United States
- Employees
- HRTX N/A
- JGH N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- JGH Investment Managers
- Sector
- HRTX Health Care
- JGH Finance
- Exchange
- HRTX Nasdaq
- JGH Nasdaq
- Market Cap
- HRTX 325.0M
- JGH 285.5M
- IPO Year
- HRTX 1987
- JGH N/A
- Fundamental
- Price
- HRTX $1.91
- JGH $12.64
- Analyst Decision
- HRTX Strong Buy
- JGH
- Analyst Count
- HRTX 2
- JGH 0
- Target Price
- HRTX $5.50
- JGH N/A
- AVG Volume (30 Days)
- HRTX 2.1M
- JGH 73.9K
- Earning Date
- HRTX 05-06-2025
- JGH 01-01-0001
- Dividend Yield
- HRTX N/A
- JGH 9.85%
- EPS Growth
- HRTX N/A
- JGH N/A
- EPS
- HRTX N/A
- JGH N/A
- Revenue
- HRTX $148,518,000.00
- JGH N/A
- Revenue This Year
- HRTX $12.60
- JGH N/A
- Revenue Next Year
- HRTX $13.66
- JGH N/A
- P/E Ratio
- HRTX N/A
- JGH N/A
- Revenue Growth
- HRTX 12.43
- JGH N/A
- 52 Week Low
- HRTX $1.04
- JGH $10.36
- 52 Week High
- HRTX $3.93
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- HRTX 45.93
- JGH 57.69
- Support Level
- HRTX $1.82
- JGH $12.47
- Resistance Level
- HRTX $1.93
- JGH $12.67
- Average True Range (ATR)
- HRTX 0.11
- JGH 0.14
- MACD
- HRTX -0.00
- JGH 0.01
- Stochastic Oscillator
- HRTX 56.76
- JGH 65.91
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.